Acute inflammation with induction of anaphylatoxin C5a and terminal complement complex C5b-9 associated with multiple intra-articular injections of hylan G-F 20: A case report

Osteoarthritis and Cartilage

Volumn 20, Issue 7, 2012, Pages 791-795

  Dragomir, C L ^a   Scott, J L ^b   Perino, G ^b   Adler, R ^b   Fealy, S ^b   Goldring, M B ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

^b Hospital for Special Surgery   (United States)

Author keywords

Acute local inflammatory reaction to hylan G F 20; Synovial fluid anaphylaxis; Terminal complement complex

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C5A; HYALURONIC ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; NEUTROPHIL MARKER MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CELL INVASION; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HYPERTROPHY; INFLAMMATION; MENISCECTOMY; MONOCYTE; NEUTROPHIL; OSTEOARTHRITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SCLEROSIS; T LYMPHOCYTE; VISCOSUPPLEMENTATION;

ACUTE DISEASE; ARTHRITIS; BIOCOMPATIBLE MATERIALS; C-REACTIVE PROTEIN; COMPLEMENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MIDDLE AGED; OSTEOARTHRITIS, KNEE; VISCOSUPPLEMENTATION; VISCOSUPPLEMENTS;

EID: 84862133498     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.03.020     Document Type: Article

References (18)

1. Food and Drug Administration Review of premarket approval application for hylan: summary of safety and effectiveness May 28, 1997, Available from:. http://www.accessdata.fda.gov/cdrh_docs/pdf/P950027a.pdf.
2. Raynauld J.P., Goldsmith C.H., Bellamy N., Torrance G.W., Polisson R., Belovich D., et al. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis. Osteoarthritis Cartilage 2005, 13:111-119.
3. Huskin J.P., Vandekerckhove B., Delincé P., Verdonk R., Dubuc J.E., Willems S., et al. Multicentre, prospective, open study to evaluate the safety and efficacy of hylan G-F 20 in knee osteoarthritis subjects presenting with pain following arthroscopic meniscectomy. Knee Surg Sports Traumatol Arthrosc 2008, 16(8):747-752.
4. Kroesen S., Schmid W., Theiler R. Induction of an acute attack of calcium pyrophosphate dihydrate arthritis by intra-articular injection of hylan G-F 20 (Synvisc). Clin Rheumatol 2000, 19(2):147-149.
5. Pullman-Mooar S., Mooar P., Sieck M., Clayburne G., Schumacher H.R. Are there distinctive inflammatory flares after hylan G-F 20 intraarticular injections?. J Rheumatol 2002 Dec, 29(12):2611-2614.
6. Goldberg V.M., Coutts R.D. Pseudoseptic reactions to hylan viscosupplementation. Clin Orthop Relat Res 2004, 419:130-137.
7. Scanzello C.R., McKeon B., Swaim B.H., DiCarlo E., Asomugha E.U., Kanda V., et al. Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms. Arthritis Rheum 2011, 63(2):391-400.
8. Girish V., Vijayalakshmi A. Affordable image analysis using NIH Image/ImageJ. Indian J Cancer 2004, 41-47.
9. Chen A.L., Desai P., Adler E.M., Di Cesare P.E. Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: a report of six cases. J Bone Joint Surg Am 2002, 84-A(7):1142-1147.
10. Iwakura Y., Nakae S., Saijo S., Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 2008 Dec, 226:57-79.
11. Corvetta A., Pomponio G., Rinaldi N., Luchetti M.M., Di Loreto C., Stramazzotti D. Terminal complement complex in synovial tissue from patients affected by rheumatoid arthritis, osteoarthritis and acute joint trauma. Clin Exp Rheumatol 1992, 10(5):433-438.
12. Kokebie R., Aggarwal R., Lidder S., Hakimiyan A.A., Rueger D.C., Block J.A., et al. The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors. Arthritis Res Ther 2011, 13(2):R50.
13. Wang Q., Rozelle A.L., Lepus C.M., Scanzello C.R., Song J.J., Larsen D.M., et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011 Nov 6, 17(12):1674-1679.
14. Cronstein Bruce N., Terkeltaub Robert The inflammatory process of gout and its treatment. Arthritis Res Ther 2006, 8(Suppl 1):S3.
15. Steinbeck M.J., Nesti L.J., Sharkey P.F., Parvizi J. Myeloperoxidase and chlorinated peptides in osteoarthritis: potential biomarkers of the disease. J Orthop Res 2007, 25(9):1128-1135.
16. Deon D., Ahmed S., Tai K., Scaletta N., Herrero C., Lee I.H., et al. Cross-talk between IL-1 and IL-6 signaling pathways in rheumatoid arthritis synovial fibroblasts. J Immunol 2001 Nov 1, 167(9):5395-5403.
17. Kaneko S., Satoh T., Chiba J., Ju C., Inoue K., Kagawa J. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther 2000, 6(2):71-79.
18. St Pierre C.A., Chan M., Iwakura Y., Ayers D.C., Kurt-Jones E.A., Finberg R.W. Periprosthetic osteolysis: characterizing the innate immune response to titanium wear-particles. J Orthop Res 2010 Nov, 28(11):1418-1424.